SCHEMBL419187

SCHEMBL419187

COC(=O)c1cc(Cl)ccc1NC(=O)C=C(Cl)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
HPGD P15428 5/20 0.46
KDM4E B2RXH2 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
ALOX12 P18054 1/20 0.43
SERPINE1 P05121 2/20 0.42
GRM4 Q14833 1/20 0.41
YAP1 P46937 1/20 0.41
SLC6A3 Q01959 1/20 0.40
HTT P42858 1/20 0.40
ABL1 P00519 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419185 1.00 ALDH1A1 (0.46) ALDH1A1HPGDKDM4ENPSR1HSD17B10
SCHEMBL419186 1.00 ALDH1A1 (0.46) ALDH1A1HPGDKDM4ENPSR1HSD17B10
SCHEMBL419256 0.87 SERPINE1 (0.56) KDM4EHSD17B10KMT2ASERPINE1
SCHEMBL29838612 0.87 SERPINE1 (0.56) KDM4EHSD17B10KMT2ASERPINE1
SCHEMBL419257 0.87 SERPINE1 (0.56) KDM4EHSD17B10KMT2ASERPINE1
SCHEMBL419255 0.87 SERPINE1 (0.56) KDM4EHSD17B10KMT2ASERPINE1
SCHEMBL495339 0.76 YAP1 (0.65) ALDH1A1KDM4EKMT2AMEN1YAP1
SCHEMBL4736951 0.76 ABL1 (0.49) ALDH1A1HPGDKDM4EHSD17B10KMT2A
SCHEMBL417977 0.74 KDM4E (0.49) ALDH1A1HPGDKDM4ENPSR1HSD17B10
SCHEMBL3870310 0.74 KDM4E (0.70) ALDH1A1KDM4ENPSR1HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2607348-B1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE INC (JP) 2021-03-17 EP disclosed
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO LTD (JP) 2014-10-02 US disclosed
US-8785473-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2014-07-22 US disclosed
EP-2607348-A2 Plasminogen Activator Inhibitor-1 Inhibitor Renascience CO., LTD. (JP) 2013-06-26 EP disclosed
EP-2415755-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Renascience CO., LTD. (JP) 2012-02-08 EP disclosed
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE CO., LTD. (JP) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 ALDH1A1 1450/4885HPGD 904/4885KDM4E 4490/4885
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 ALDH1A1 1450/4885HPGD 904/4885KDM4E 4490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.